Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice†

Abstract

Treatment of ob/ob mice with rosiglitazone did not reverse histological lesions of NAFLD or improve MRC activity. On the contrary, rosiglitazone reduced activity of complex I and increased oxidative stress and liver steatosis.